Form 4 for SNOA Sonoma Pharmaceuticals, Inc.
Accepted 2024-06-21 00:00:00 ET · period of report 2024-06-20 · accession 0001683168-24-004426 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-21 | 2024-06-20 | SNOA | Trombly Amy Moss | CEO | A - Grant | — | +53.6K | 153.6K | +54% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2024-06-20 | A | A | 53,586 | — | 153,586 | D | — | — | (F1) The shares of common stock were awarded and granted as Restricted Stock Units to Ms. Trombly for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date. |